William D Travis


Affiliation: Memorial Sloan-Kettering Cancer Center
Country: USA


  1. Travis W, Brambilla E, Noguchi M, Nicholson A, Geisinger K, Yatabe Y, et al. International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol. 2011;6:244-85 pubmed publisher
  2. request reprint
    Travis W, Garg K, Franklin W, Wistuba I, Sabloff B, Noguchi M, et al. Bronchioloalveolar carcinoma and lung adenocarcinoma: the clinical importance and research relevance of the 2004 World Health Organization pathologic criteria. J Thorac Oncol. 2006;1:S13-9 pubmed
    ..More work is needed to determine the most important prognostic pathologic features in lung adenocarcinoma. ..
  3. Travis W, Giroux D, Chansky K, Crowley J, Asamura H, Brambilla E, et al. The IASLC Lung Cancer Staging Project: proposals for the inclusion of broncho-pulmonary carcinoid tumors in the forthcoming (seventh) edition of the TNM Classification for Lung Cancer. J Thorac Oncol. 2008;3:1213-23 pubmed publisher
    ..A prospective collection of data through an International Registry of Pulmonary Neuroendocrine Tumors planned by the IASLC will allow for further detailed analysis of staging data for broncho-pulmonary carcinoids. ..
  4. Travis W, Brambilla E, Noguchi M, Nicholson A, Geisinger K, Yatabe Y, et al. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society: international multidisciplinary classification of lung adenocarcinoma: executive summary. Proc Am Thorac Soc. 2011;8:381-5 pubmed publisher
    ..This classification is intended to support clinical practice as well as research investigation and clinical trials. ..
  5. Kameda K, Eguchi T, Lu S, Qu Y, Tan K, Kadota K, et al. Implications of the Eighth Edition of the TNM Proposal: Invasive Versus Total Tumor Size for the T Descriptor in Pathologic Stage I-IIA Lung Adenocarcinoma. J Thorac Oncol. 2018;13:1919-1929 pubmed publisher
  6. Travis W, Hunninghake G, King T, Lynch D, Colby T, Galvin J, et al. Idiopathic nonspecific interstitial pneumonia: report of an American Thoracic Society project. Am J Respir Crit Care Med. 2008;177:1338-47 pubmed publisher
    ..Five-year survival was 82.3%. Idiopathic NSIP is a distinct clinical entity that occurs mostly in middle-aged women who are never-smokers. The prognosis of NSIP is very good. ..
  7. Motoi N, Szoke J, Riely G, Seshan V, Kris M, Rusch V, et al. Lung adenocarcinoma: modification of the 2004 WHO mixed subtype to include the major histologic subtype suggests correlations between papillary and micropapillary adenocarcinoma subtypes, EGFR mutations and gene expression analysis. Am J Surg Pathol. 2008;32:810-27 pubmed publisher
    ..Such an approach should be considered in future studies for validation in other datasets. ..
  8. Travis W. Pathology of lung cancer. Clin Chest Med. 2011;32:669-92 pubmed publisher
    ..Histologic criteria are also presented for other tumors. ..
  9. Travis W, Brambilla E, Nicholson A, Yatabe Y, Austin J, Beasley M, et al. The 2015 World Health Organization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification. J Thorac Oncol. 2015;10:1243-1260 pubmed publisher
    ..to sclerosing pneumocytoma, (10) changing the name hamartoma to "pulmonary hamartoma," (11) creating a group of PEComatous tumors that include (a) lymphangioleiomyomatosis, (b) PEComa, benign (with clear cell tumor as a variant) and ..

More Information


  1. request reprint
    Travis W, Garg K, Franklin W, Wistuba I, Sabloff B, Noguchi M, et al. Evolving concepts in the pathology and computed tomography imaging of lung adenocarcinoma and bronchioloalveolar carcinoma. J Clin Oncol. 2005;23:3279-87 pubmed
    ..Hopefully, this work will allow definition of a category of adenocarcinoma, mixed subtype with predominant BAC/minimal invasion and a favorable prognosis. ..
  2. Travis W. Reporting lung cancer pathology specimens. Impact of the anticipated 7th Edition TNM classification based on recommendations of the IASLC Staging Committee. Histopathology. 2009;54:3-11 pubmed publisher
    ..TNM staging of carcinoid tumours and small cell carcinoma is also discussed. ..
  3. Galateau Salle F, Churg A, Roggli V, Travis W. The 2015 World Health Organization Classification of Tumors of the Pleura: Advances since the 2004 Classification. J Thorac Oncol. 2016;11:142-54 pubmed publisher
    ..Finally, desmoid type fibromatosis, a locally aggressive tumor that can present in the pleura, has been shown to frequently have CTNNB1 gene mutations and express β-catenin by immunohistochemistry. ..
  4. Travis W, Asamura H, Bankier A, Beasley M, Detterbeck F, Flieder D, et al. The IASLC Lung Cancer Staging Project: Proposals for Coding T Categories for Subsolid Nodules and Assessment of Tumor Size in Part-Solid Tumors in the Forthcoming Eighth Edition of the TNM Classification of Lung Cancer. J Thorac Oncol. 2016;11:1204-1223 pubmed publisher
  5. Schilsky J, Ni A, Ahn L, Datta S, Travis W, Kris M, et al. Prognostic impact of TTF-1 expression in patients with stage IV lung adenocarcinomas. Lung Cancer. 2017;108:205-211 pubmed publisher
    ..In patients with advanced lung adenocarcinomas, TTF-1 expression is associated with better survival but is not predictive of distinct benefit from pemetrexed-based chemotherapy. ..
  6. Lu S, Tan K, Kadota K, Eguchi T, Bains S, Rekhtman N, et al. Spread through Air Spaces (STAS) Is an Independent Predictor of Recurrence and Lung Cancer-Specific Death in Squamous Cell Carcinoma. J Thorac Oncol. 2017;12:223-234 pubmed publisher
    ..Our findings suggest that STAS is one of the most prognostically significant histologic findings in lung SCC. ..